Tags » Gleevec

Orphan Drugs: The Power Of Multiple Indications

Orphan drug companies have used with tremendous success as part of their drug life cycle management, the strategy to extend the life of their product by devising a succession of multiple discrete indications for the orphan drug. 577 more words

Orphan Drug Development

Whoopsie!

Accidentally deleted my last post.  I’ll blame it on the “Gleevec Fog”.

To recap, my dosage of Gleevec was increased, then decreased due to unacceptable and overwhelming side effects.  80 more words

Chronic Myeloid Leukemia